We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-8.89%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.51B
AUM Growth
-$307M
Cap. Flow
+$14.9M
Cap. Flow %
0.6%
Top 10 Hldgs %
23.56%
Holding
327
New
15
Increased
111
Reduced
164
Closed
21

Top Buys

Rank Stock Value
1
APPS icon
Digital Turbine
APPS
+$22.2M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$11.6M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$7.01M
4
CHUY
Chuy's Holdings, Inc. Common Stock
CHUY
+$6.39M
5
MATV icon
Mativ Holdings
MATV
+$5.91M

Top Sells

Rank Stock Value
1
MIME
Mimecast Limited
MIME
+$15.9M
2
ZGNX
Zogenix, Inc.
ZGNX
+$12.6M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$11.1M
4
NPTN
NEOPHOTONICS CORP
NPTN
+$6.5M
5
COLL icon
Collegium Pharmaceutical
COLL
+$5.04M

Sector Composition

Rank Sector Weight
1 Technology 29.36%
2 Healthcare 23.72%
3 Industrials 14.58%
4 Consumer Discretionary 12.89%
5 Communication Services 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FC icon
51
Franklin Covey
FC
$241M
$15M 0.6%
330,647
+3,207
+1% +$149K
PTC icon
52
PTC
PTC
$16.6B
$14.3M 0.57%
132,613
-4,550
-3% -$511K
ALBO
53
DELISTED
Albireo Pharma Inc
ALBO
$14.2M 0.56%
474,991
+16,980
+4% +$497K
SNBR
54
DELISTED
Sleep Number
SNBR
$13.8M 0.55%
272,926
+4,545
+2% +$308K
GBT
55
DELISTED
Global Blood Therapeutics, Inc.
GBT
$13.3M 0.53%
383,752
+8,234
+2% +$246K
CMBM
56
DELISTED
Cambium Networks
CMBM
$13.3M 0.53%
561,216
+164,062
+41% +$3.97M
PCOM
57
DELISTED
Points.com Inc. Common Shares
PCOM
$13.1M 0.52%
707,230
+11,869
+2% +$199K
EBS icon
58
Emergent Biosolutions
EBS
$229M
$12.4M 0.5%
302,721
-40,626
-12% -$1.79M
LMAT icon
59
LeMaitre Vascular
LMAT
$1.83B
$12.2M 0.48%
261,873
+6,781
+3% +$303K
GXO icon
60
GXO Logistics
GXO
$5.44B
$12.1M 0.48%
169,464
-3,089
-2% -$247K
TFX icon
61
Teleflex
TFX
$5.95B
$12.1M 0.48%
34,050
-995
-3% -$328K
ETSY icon
62
Etsy
ETSY
$7.52B
$11.8M 0.47%
94,661
-3,474
-4% -$516K
ACAD icon
63
Acadia Pharmaceuticals
ACAD
$5.07B
$11.2M 0.45%
463,304
+2,253
+0.5% +$54.5K
UTMD icon
64
Utah Medical Products
UTMD
$228M
$10.5M 0.42%
116,613
+2,780
+2% +$256K
PRGS icon
65
Progress Software
PRGS
$1.78B
$10.1M 0.4%
214,875
+60,103
+39% +$2.71M
CCSI icon
66
Consensus Cloud Solutions
CCSI
$668M
$10.1M 0.4%
168,006
-2,462
-1% -$142K
ACLS icon
67
Axcelis
ACLS
$4.09B
$9.93M 0.4%
131,512
-11,937
-8% -$815K
KPTI icon
68
Karyopharm Therapeutics
KPTI
$45.1M
$9.91M 0.4%
89,662
+4,553
+5% +$567K
FATE icon
69
Fate Therapeutics
FATE
$323M
$9.53M 0.38%
245,916
-4,296
-2% -$166K
AAP icon
70
Advance Auto Parts
AAP
$3.37B
$9.12M 0.36%
44,045
-1,569
-3% -$345K
COLL icon
71
Collegium Pharmaceutical
COLL
$885M
$8.9M 0.35%
437,200
-267,001
-38% -$5.04M
ATEN icon
72
A10 Networks
ATEN
$2.05B
$8.59M 0.34%
615,842
+1,202
+0.2% +$16.9K
CSW
73
CSW Industrials
CSW
$5.61B
$8.27M 0.33%
70,354
+2,680
+4% +$315K
KNSA icon
74
Kiniksa Pharmaceuticals
KNSA
$6B
$8.07M 0.32%
811,922
+99,115
+14% +$1.05M
ITRN icon
75
Ituran Location and Control
ITRN
$1.04B
$7.92M 0.32%
344,203
+6,227
+2% +$145K
1 2
3
4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Rice Hall James & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Rice Hall James & Associates held 327 positions worth $2.51B, down 11% from $2.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q1 2022 filing shows 15 new, 111 increased, 164 reduced and 21 closed positions. Its largest new stake was Digital Turbine: 491,443 shares worth $21.5M. The largest sale was Mimecast Limited, an estimated $15.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Rice Hall James & Associates's largest Q1 2022 buy was Digital Turbine: 491,443 shares worth $21.5M.
  • Rice Hall James & Associates added most to Neurocrine Biosciences in Q1 2022, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q1 2022 reduction was Mimecast Limited, cutting an estimated $15.9M.
  • Rice Hall James & Associates fully exited Zogenix, Inc. in Q1 2022, selling an estimated $12.6M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.51B portfolio in Q1 2022.
  • Rice Hall James & Associates opened 15 new positions and closed 21 in Q1 2022.
  • Rice Hall James & Associates's portfolio value fell 11% quarter-over-quarter to $2.51B.

Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.